Clinical Trials on Fatigue in Multiple Sclerosis
Total 3326 results
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisGermany
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisKorea, Republic of, Taiwan, Czechia, Japan, Poland
-
Eli Lilly and CompanyCompletedRelapsing-Remitting Multiple SclerosisHungary, United States, France, Ukraine, Poland, Germany, Israel, Russian Federation, Czechia, Serbia, Romania, Slovakia, Bulgaria
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisGermany, Hungary, Czechia, Russian Federation, India, Poland, Ukraine, United Kingdom
-
Nantes University HospitalCompletedRelapsing-remitting Multiple SclerosisFrance
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisGermany
-
Universita di VeronaCompletedRelapsing-Remitting Multiple SclerosisItaly
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisItaly
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisBelgium, Bulgaria, Canada, Croatia, Czech Republic, Finland, Germany, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Turkey, Ukraine, United Kingdom
-
Claudio GobbiOspedale Civico, LuganoCompletedRelapsing-remitting Multiple SclerosisSwitzerland
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Claudio GobbiBayerTerminatedRelapsing-remitting Multiple SclerosisSwitzerland
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S, FranceCompletedMultiple Sclerosis, Relapsing, Remitting
-
Coordinación de Investigación en Salud, MexicoCompleted
-
NovartisCompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)Relapsing-remitting Multiple SclerosisCanada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
-
Universita di VeronaCompletedRelapsing-remitting Multiple SclerosisItaly
-
University Hospital Inselspital, BernePharmaPart; Viollier AG, Basel, SwitzerlandCompletedRelapsing-remitting Multiple SclerosisSwitzerland
-
Cantonal Hospital of St. GallenUnknownRelapsing-Remitting Multiple SclerosisSwitzerland
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFinland
-
NeurognosticsCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Charite University, Berlin, GermanyRecruitingAlarm Fatigue | Mortality in Intensive Care Units | Complications InfectionGermany
-
University of Alabama at BirminghamWashington University School of Medicine; United States Department of DefenseRecruitingRelapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Friedemann PaulRoche Pharma AGActive, not recruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveGermany
-
Charite University, Berlin, GermanyCompletedRelapsing-Remitting Multiple SclerosisGermany
-
MediciNovaNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes... and other collaboratorsCompletedSafety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple SclerosisMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
Providence Multiple Sclerosis CenterBiogenCompletedClinically Isolated Syndrome | Relapsing-remitting Multiple SclerosisUnited States
-
IMS HEALTH GmbH & Co. OHGEMD SeronoCompletedRelapsing-remitting Multiple SclerosisUnited States, Canada
-
BayerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)China, Slovakia, France, Germany, Korea, Republic of, Saudi Arabia, Singapore, Sweden, Taiwan, Colombia, Czech Republic, Estonia, Italy, Jordan, Lebanon, Mexico, Slovenia, United Kingdom, Argentina, Bahrain, Egypt, United Arab Emirates and more
-
Hospices Civils de LyonFondation pour la Recherche MédicaleCompletedChronic Optic Neuropathy in Multiple SclerosisFrance
-
Hoffmann-La RocheActive, not recruitingRelapsing Multiple Sclerosis | Primary Progressive Multiple SclerosisSpain, United States, Italy, Poland, Turkey, New Zealand, Czechia, Brazil
-
Cellerys AGNovartis; Tetec AG; Scope International AG; Jung Diagnostics GmbHNot yet recruitingRelapsing-remitting Multiple Sclerosis (RRMS)
-
Novartis PharmaceuticalsRecruitingRelapsing-Remitting Multiple SclerosisCanada, United States
-
Immunic AGActive, not recruitingRelapsing-Remitting Multiple Sclerosis (RRMS)Poland, Bulgaria, Romania, Ukraine
-
BiogenAbbVieTerminatedRelapsing-Remitting Multiple Sclerosis (RRMS)Italy, United States, Canada, Germany, Puerto Rico
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple Sclerosis (RRMS)Belgium, Mexico, Poland, Romania, Saudi Arabia, Ukraine
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States
-
EMD SeronoPfizerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)United States
-
Carmel Medical CenterTerminated
-
University Hospital of Mont-GodinneUniversité Catholique de Louvain; Teva Pharmaceuticals USATerminatedRelapsing Remitting Multiple Sclerosis | Motor Deficits | Cognitive Deficits | Secondary-progressive Multiple SclerosisBelgium
-
Hospital Universitari Vall d'Hebron Research InstituteActive, not recruitingQuality of Life | Multiple Sclerosis | Fatigue | Patient Empowerment | Peer Group | Patient ActivationSpain
-
Pamukkale UniversityNot yet recruitingMultiple Sclerosis | Fatigue | Reliability | Validity | Cultural Adaptation
-
Leonardo A. Peyré-TartarugaAline Nogueira Haas; Flávia Gomes MartinezNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveBrazil
-
Cyprus University of TechnologyCyprus Institute of Neurology and GeneticsCompletedMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveCyprus
-
National Center of Neurology and Psychiatry, JapanCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveJapan
-
Casa Sollievo della Sofferenza IRCCSNeurocenter of Southern Switzerland; Associazione Revert ONLUS; Fondazione Cellule...CompletedSecondary-progressive Multiple SclerosisItaly, Switzerland
-
University of Massachusetts, LowellOhio State UniversityCompletedHemiparesis | Primary Progressive Multiple SclerosisUnited States
-
Rennes University HospitalRecruitingMultiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveFrance
-
Amsterdam UMC, location VUmcRecruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveNetherlands